SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses

[1] Caillard S(2021)Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant 21 1295-1303

[2] Chavarot N(2020)An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants Kidney Int 98 1549-1558

[3] Francois H(2020)COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium Am J Transplant 20 3140-3148

[4] Matignon M^#(2020)COVID-19 infection in kidney transplant recipients at the epicenter of pandemics Kidney Int 98 1559-1567

[5] Greze C(2021)An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients Am J Transplant 21 2522-2531

[6] Kamar N(2021)COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature Transplant Rev (Orlando) 35 329-338

[7] Caillard S(2020)COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: a systematic review of cases Transpl Infect Dis 22 233-236

[8] Anglicheau D(2021)COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients J Infect 82 2586-2588

[9] Matignon M(2021)Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited Cancer Discov 11 1901-12.e9

[10] Durrbach A(2020)Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer N Engl J Med 383 293-303

[1] Caillard S(2021)Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant 21 1295-1303

[2] Chavarot N(2020)An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants Kidney Int 98 1549-1558

[3] Francois H(2020)COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium Am J Transplant 20 3140-3148

[4] Matignon M^#(2020)COVID-19 infection in kidney transplant recipients at the epicenter of pandemics Kidney Int 98 1559-1567

[5] Greze C(2021)An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients Am J Transplant 21 2522-2531

[6] Kamar N(2021)COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature Transplant Rev (Orlando) 35 329-338

[7] Caillard S(2020)COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: a systematic review of cases Transpl Infect Dis 22 233-236

[8] Anglicheau D(2021)COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients J Infect 82 2586-2588

[9] Matignon M(2021)Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited Cancer Discov 11 1901-12.e9

[10] Durrbach A(2020)Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer N Engl J Med 383 293-303